Platform Group Se & Co. Kgaa · XETR:TPG0
Platform Group Se & Co. Kgaa — The Platform Group SE & Co. KGaA — FY2025 Earnings Presentation
46 slides from Platform Group Se & Co. Kgaa's earnings presentation, Jan 27, 2026
Slide 1: Investor Presentation: Preliminary Financial Results 2025, AEP & Outlook 2026
INVESTOR PRESENTATION PRELIMINARY FINANCIAL RESULTS FOR THE 2025 FINANCIAL YEAR, AEP & OUTLOOK 2026 JANUARY 27, 2026 Investor Presentation Investor Presentation 1
Slide 2: Agenda: Platform Group Introduction & Updates
Agenda PLATFORM GROUP INTRODUCTION & UPDATES Investor Presentation Investor Presentation 2
Slide 3: Our Management Structure
OUR MANAGEMENT STRUCTURE Supervisory Board Stefan Schütze Marcel Roessner Florian Müller Dr. Olaf Hoppelshäuser Chairman C-level member in the luxury Entrepreneur and experienced Member of the Board of Directors Managing Partner of C3 and ecommerce sector C-Level Manager at Alliance Group Management
Slide 4: Company History: The Platform Group
COMPANY HISTORY: THE PLATFORM GROUP TPG MILESTONES: FROM LEGACY TO GLOBAL PLATFORM 2012 2025 2030 Digital Ecosystem Vision for Growth Transformation Expansion Dr. Dominik Benner pivots the TPG operates 34 platforms, TPG aims to connect over 1882 founded family shoe connecting over 16,600 40,000 merc
Slide 5: Value Creation
VALUE CREATION OUR UNIQUE SYSTEM TO CONNECT PARTNERS AND CUSTOMERS WORLDWIDE 1882 originated 35 platforms Partners Customers >6.7m customers +16,600 partners 26 industries KEY FEATURES ASSET LIGHT SOFTWARE ENABLED PROCESS EXCELLENCE PARTNER CENTRIC STRATEGY DRIVEN Investor Presentation Investor Pres
Slide 6: TPG's Share Development
TPG‘S SHARE DEVELOPMENT DEVELOPMENT OF SHARE SINCE 12/2022 & TRADING VOLUME SHARE DEVELOPMENT SINCE DEC 2022 – DEC 2025 MARKET SNAPSHOT Share ISIN/ Ticker: DE000A2QEFA1 / TPG No. of shares (m): 20.5 Market cap EUR m: 103 Freefloat MC EUR m: 33 Ø daily Trad. Vol.: 435,605 Trading venue: XETRA, XFRA,
Slide 7: TPG's Share Development: Increased Liquidity
TPG‘S SHARE DEVELOPMENT INCREASED LIQUIDITY DRIVEN BY STRONGER FOREIGN INVESTOR PARTICIPATION LIQUIDIITY CONTINUES TO STRENGTHEN RISING INTERNATIONAL MARKET PARTICIPATION 4.5x +168% increase in trading increase in foreign Turnover for the last 12 month (in €m) volume Total turnover (EUR) on Xetra an
Slide 8: TPG's Share & Bond Development
TPG‘S SHARE & BOND DEVELOPMENT TPG STOCK AND BOND WITH NEGATIVE DEVELOPMENT IN LAST 4 MONTHS SHARE DEVELOPMENT 2025 BOND DEVELOPMENT 2025 Fragmented German bond market TPG Share price 2025: Price movements of TPG Bond: ▪ 29%, impacted by market volatility, investor structure and one-off effects ▪ Pr
Slide 9: Industries Covered with 5 Segments
26 INDUSTRIES COVERED WITH 5 SEGMENTS ECOMMERCE Consumer Goods Industrial Goods Optics & Hearing (7/2025) Freight Goods Pharma & Retail Goods Investor Presentation Investor Presentation 9
Slide 10: Growth Pillars – How We Scale the TPG Platform
GROWTH PILLARS – HOW WE SCALE THE TPG PLATFORM 1. M&A DEVELOPMENTS 2025 STRENGTHEN EXISTING SEGMENTS ENTER NEW INDUSTRIES Luxury/ Pharma Optics & Outdoor B2B B2B SaaS Fashion Hearing Products Construction Jan 2026 Furniture Pet Food ▪ Acquire companies that deepen expertise, add supply, or • Add ent
Slide 11: TPG's Luxury Portfolio
TPG‘S LUXURY PORTFOLIO LUXURY PORTFOLIO COMPLIMENTED WITH WELL SUITED ADDITIONS FASHIONETTE (Fashion & Vintage Secondhand Luxury Market is 3x faster growing than firsthand Luxury) Focuses on premium & luxury fashion items, including handbags and $360b accessories from top designers. $220b 2030 CHRON
Slide 12: Growth Pillars: Merchant/Partner Expansion 2025
GROWTH PILLARS – HOW WE SCALE THE TPG PLATFORM 2. MERCHANT/ PARTNER EXPANSION 2025 ▪ Growing partner base: onboarding of new retailers/ merchants into the platform ecosystem ▪ Software TPG One as enabler for fast onboarding and scalable business ▪ Local retailers can “go online” via TPG and sell the
Slide 13: Latest Developments (3 Month): M&A Acquisitions
LATEST DEVELOPMENTS (3 MONTH) M&A ACQUISITIONS Acquisition of Acquisition of Acquisition of apothekia GmbH 43einhalb GmbH AEP GmbH (B2B pharma training platform) (B2C platform for fashion and (B2B platform pure-play footwear) pharmaceutical wholesaler) Source(s): Company Information Investor Present
Slide 14: Organizational Structure: The Platform Group SE & Co. KGaA
LATEST DEVELOPMENTS (3 MONTH) ORGANIZATIONAL STRUCTURE: THE PLATFORM GROUP SE & CO. KGAA 2/2 Stock listed holding The Platform Group SE & Co. KGaA General Partner The Platform Group SE (until December 2025 The Platform Group AG) (no operational function) 100% 100% 100% The Platform Group Fashionette
Slide 15: Agenda: AEP Acquisition
Agenda PLATFORM GROUP AEP ACQUISITION Investor Presentation Investor Presentation 15
Slide 16: Strategic Rationale Behind the Acquisition of AEP
THE STRATEGIC RATIONALE BEHIND THE ACQUISITION OF AEP > SEEKING STRATEGIC FIT AND VALUE GROWTH FOR A SUSTAINABLE INVESTMENT ▪ Online education ▪ Online platform ▪ B2B platform partner of platform for > 40.500 with 38.800 connected >7.000 local pharmacies users in Germany pharmacies and 300 and 560 m
Slide 17: Strategic Rationale Behind the Acquisition of AEP
THE STRATEGIC RATIONALE BEHIND THE ACQUISITION OF AEP > SEEKING STRATEGIC FIT AND VALUE GROWTH FOR A SUSTAINABLE INVESTMENT Pharma Online Platform Manufacturers Use ApoNow for Direct B2C orders selling online for customers (incl. E Rezept) Sell Orders from online products platform to local to pharma
Slide 18: Strategic Rationale Behind the Acquisition of AEP
THE STRATEGIC RATIONALE BEHIND THE ACQUISITION OF AEP ▪ The business is healthy with stable demand, recurring B2B orders and resilient pharma end-market, albeit with tight margins. ▪ Drivers are volume growth in prescriptions/OTC, new pharmacy customers and share CHANCES FOR gains from weaker wholes
Slide 19: AEP at a Glance (1/4)
AEP AT A GLANCE (1/4) History ▪ Founded in 2012 as a pure-play pharmaceutical wholesaler / B2B platform ▪ Central, highly automated distribution hub established in Alzenau, Germany ▪ Rapid scale-up from 500m € revenues (2021) to ~1bn € by 2025 ▪ Increase of profitability (~€20m EBITDA, IFRS) due to
Slide 20: AEP at a Glance (2/4)
AEP AT A GLANCE (2/4) Business model / services Sources: Company information Investor Presentation Investor Presentation 20
Slide 21: AEP at a Glance (3/4)
AEP AT A GLANCE (3/4) Business model / services Top suppliers (in total: 560 suppliers) ▪ Strong growth 2020-2025 and increased profitability ▪ Cost and price leader for local pharmacies Key features ▪ Delivery once daily to 7,000 pharmacies ▪ Wholesale licence according to § 52a AMG (German Medicin
Slide 22: AEP at a Glance (4/4)
AEP AT A GLANCE (4/4) Business model / services Customer Structure ▪ Singing done (January 26, 2026) ▪ German Federal Cartel Office procedure/approval (2-4 months) Transaction of ▪ Conditions precedent according to SPA AEP ▪ Closing in Q2 2026 expected Sources: Company information Investor Presentat
Slide 23: One Pharma Group Is Formed
ONE PHARMA GROUP IS FORMED > ▪ Online platform ▪ B2B platform partner of ▪ Online education with 38.800 connected >7.000 local pharmacies platform for > 40.500 pharmacies and 300 and 560 manufacturers 23 users in Germany manufacturers ▪ >8.000 pharmacies € 1.1 bn € 25 m 320 Revenue Adj. EBITDA Emplo
Slide 24: Agenda: Financials
Agenda PLATFORM GROUP FINANCIALS Investor Presentation Investor Presentation 24
Slide 25: Developments FY 2025
DEVELOPMENTS FY 2025 Developments FY 2025 11 signings/acquisitions in 2025. Strong Post-Merger-Management team (PMI). 3 divestments in Q4 2025. Improved profitability in 2025 (+65% EBITDA adj.) due to cost efficiencies and scalable cost structure Further decrease of operational costs: Distribution,
Slide 26: Guidance 2025: Preliminary Results in Line
GUIDANCE 2025 Preliminary Results in line with guidance Guidance > € 715-735 m € 54-58 m 1.5-2.3x Revenue € 728 m € 55 m Adj. EBITDA Leverage 2.2x Guidance € 1.3 bn >16,500 Preliminary results GMV € 1.3 bn 16,610 Partners 2025 Sources: Company, FY 2025 all numbers are unaudited and preliminary. Inve
Slide 27: Strong GMV and Revenue Growth
STRONG GMV AND REVENUE GROWTH PRELIMINARY FINANCIAL RESULT 2025 GMV Growth FY Revenue Growth FY +44% +39% € 1.3 bn YoY YoY € 728 m € 903 m € 524.6 m 2024 2025 2024 2025 Sources: Company, FY 2025 all numbers are unaudited and preliminary. Investor Presentation Investor Presentation 27
Slide 28: Strong GMV and Revenue Growth: EBITDA and Net Profit
STRONG GMV AND REVENUE GROWTH PRELIMINARY FINANCIAL RESULT 2025 EBITDA adj FY Net profit FY +65% +42% € 55.0 m YoY YoY € 46.5 m € 33.2 m € 32.7 m 2024 2025 2024 2025 Sources: Company, FY 2025 all numbers are unaudited and preliminary. Investor Presentation Investor Presentation 28
Slide 29: Profitability as a Key for Sustainable Growth
PROFITABILITY AS A KEY FOR SUSTAINABLE GROWTH REVENUE & EBITDA ADJ. MARGIN 3 YEARS € 728.1 m € 524.6m € 440.8 m € 33.3m € 17.6m € 13.2m 7.6% 5.1% 6.3% 2023 2024 2025 Sources: Company, 2023 pro-forma figures, 2025 preliminary figures. Investor Presentation Investor Presentation 29
Slide 30: Preliminary Financial Results 2025
PRELIMINARY FINANCIAL RESULTS 2025 STRONG PROFITABLE GROWTH 2024 2025 Takeaways GMV (EUR m) € 903.2m € 1.3bn Net revenue (EUR m) € 524.6m € 728.1m GMV Growth +44% / Revenue Growth +38.8%: both in line with our increased guidance Other revenues (EUR m) € 29.1m € 24.4m Increased Gross Margin due to le
Slide 31: Preliminary Financial Results 2025
PRELIMINARY FINANCIAL RESULTS 2025 STRONG PROFITABLE GROWTH 2024 2025 Takeaways Net profit (EUR m) € 32.7m € 46.5m Earnings per share with € 2.26 and growth of +41%: thereof minorities € 1.6m € 4.5m in line with forecast Increase of minority results (€4.5m) due to new Earnings per share (EUR), total
Slide 32: Debt Development Over Time
PRELIMINARY FINANCIAL RESULTS 2025 DEBT DEVELOPMENT OVER TIME DEBT LEVERAGE Debt Leverage & Cash Flow Conservative debt levels & increase in cash flow 2.7x ▪ With our conservative debt strategy, we will reduce the 2.6x net debt level to 1.8x (net debt to EBITDA adj.) 2.2x ▪ We choose long term loan
Slide 33: Our Organic Growth
OUR ORGANIC GROWTH STRONG ORGANIC GROWTH IN 2025 / HIGHER THAN PREVIOUS YEAR RISING ORGANIC GROWTH RATE REASONS FOR HIGHER ORGANIC GROWTH RATE Ratio between organic / non-organic growth (in % of total € revenue growth) Main reasons for higher organic growth rates: 2025 2024 1. Higher number of partn
Slide 34: Our AI Strategy to Increase Profitability
OUR AI STRATEGY TO INCREASE PROFITABILITY > AI optimized “AI first + cost reduction program” processes: We will change to an AI first strategy and start a cost reduction program to achieve margin improvements >60% through AI measures ▪ AI will change our business, eCommerce and software development
Slide 35: Agenda: Outlook & Strategy
Agenda PLATFORM GROUP OUTLOOK & STRATEGY Investor Presentation Investor Presentation 35
Slide 36: Our Vision for 2030
OUR VISION FOR 2030 Double-digit <1.8 x € 3.0 bn margins Revenue EBITDA Leverage € 4.5 bn >40,000 >50 GMV Partners Industries covered Investor Presentation Investor Presentation 36
Slide 37: Strategic Dimensions
STRATEGIC DIMENSIONS OUR STRATEGIC INITIATIVES AND GOALS Geographic & Marketplace Expansion Growth through M&A & Ecosystem Expansion ▪ Currently ~70% revenues from DACH + Netherlands. ▪ Disciplined acquisition strategy: each acquisition brings new ▪ Strong opportunity to expand further across Europe
Slide 38: Our Vision for 2030: Track Record of Revenue Growth
OUR VISION FOR 2030 > TRACK RECORD OF REVENUE GROWTH SUPPORTING OUR VISION € 3.0 bn + €2.0 bn (~ 31.6% CAGR) € 1.0 bn + €0.7 bn (~ 30% CAGR) € 0.3 bn 2022 2026e 2030e Investor Presentation All growth numbers include organic and anorganic options. 2022 pro-forma figures. 2026e according to Guidance 2
Slide 39: Our Vision for 2030: Scale, Synergy and M&A
OUR VISION FOR 2030 > SCALE, SYNERGY AND M&A AS GROWTH FACTORS OUR GROWTH FACTORS (in EUR) € 3.0 bn € 0.8 bn € 0.3 M&A bn in existing SYNERGY: € 0.9 segments bn New € 1.0 bn Industries ORGANIC: + US-Entry New Partners/ 2026e products 2030e Investor Presentation All growth numbers include organic and
Slide 40: Guidance 2026 (Without AEP)
GUIDANCE 2026 (WITHOUT AEP) € 1.0 bn € 70-80 m 1.5-2.3x Revenue Adj. EBITDA Leverage € 1.7 bn >18,000 GMV Partners Investor Presentation Investor Presentation 40
Slide 41: Guidance 2026 (With AEP, Pro-forma)
GUIDANCE 2026 (WITH AEP, PRO-FORMA) € 2.0 bn € 90-100 m 1.5-2.3x Revenue Adj. EBITDA Leverage € 3.0 bn >25,000 GMV Partners Investor Presentation Investor Presentation 41
Slide 42: Guidance 2026 (With AEP, Pro-forma)
GUIDANCE 2026 (WITH AEP, PRO-FORMA) Revenue Guidance 2026 EBITDA adj. Guidance 2026 € 2.0 bn € 90-100 m € 1.0 bn € 70-80 m TPG TPG TPG TPG STAND ALONE WITH AEP STAND ALONE WITH AEP Investor Presentation AEP acquisition expected with closing in Q2 2026, presented figures show pro-forma figures after
Slide 43: Investor Relations: Financial Calendar & Contact
INVESTOR RELATIONS FINANCIAL CALENDAR & CONTACT DATE EVENT Nathalie Richert NOV 23, 2026 GERMAN EQUITY FORUM 23 - 25 NOVEMBER, FRANKFURT , FRANKFURT Head of Investor Relations +49 157 92511 140 NOV 05, 2026 PUBLICATION QUARTERLY STATEMENT (CALL-DATE Q3) ir@the-platform-group.com OCT 06, 2026 QUIRIN
Slide 44: Investor Presentation Investor Presentation
Investor Presentation Investor Presentation 44
Slide 45: Disclaimer
DISCLAIMER This document has been prepared by The Platform Group SE & Co. KGaA (TPG) solely for informational purposes. This disclaimer shall apply in all respects to the entire presentation, including any oral presentation of the slides by the representatives of the Company (or any other person on
Slide 46: The Platform Group SE & Co. KGaA Investor Relations
The Platform Group SE & Co. KGaA Investor Relations Schloss Elbroich, Am Falder 4 40589 Düsseldorf , Germany ir@the-platform-group.com https://corporate.the-platform-group.com Investor Presentation Investor Presentation 46
The Platform Group SE & Co. KGaA — FY2025 Earnings Presentation on 6ix